Inactive Instrument

Company Iqvia Holdings Inc Nyse

Equities

US74876Y1010

Biotechnology & Medical Research

Business Summary

Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:

- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;

- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;

- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.

Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).

Sales per Business

USD in Million2022Weight2023Weight Delta
Research and Development Solutions
56.0 %
7,921 55.0 % 8,395 56.0 % +5.98%
Technology and Analytics Solutions
39.1 %
5,746 39.9 % 5,862 39.1 % +2.02%
Contract Sales and Medical Solutions
4.9 %
743 5.2 % 727 4.9 % -2.15%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
45.0 %
6,052 42.0 % 6,743 45.0 % +11.41%
Europe and Africa
29.8 %
4,366 30.3 % 4,459 29.8 % +2.13%
Asia-Pacific
19.8 %
2,996 20.8 % 2,973 19.8 % -0.77%
Americas
5.4 %
996 6.9 % 809 5.4 % -18.74%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 16-10-02
Director of Finance/CFO 63 20-07-31
Chief Operating Officer 51 17-06-30
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 17-10-31
Chief Tech/Sci/R&D Officer 61 16-10-31
Investor Relations Contact - 21-03-31
Comptroller/Controller/Auditor 40 19-02-28
Corporate Officer/Principal 45 -
Corporate Officer/Principal 55 17-06-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 16-10-02
Director/Board Member 68 17-07-26
Chief Executive Officer 63 16-10-02
Director/Board Member 58 07-12-31
Director/Board Member 54 16-10-02
Director/Board Member 66 15-02-04
Director/Board Member 52 15-12-31
Director/Board Member 66 19-02-20
Director/Board Member 66 22-01-25
Director/Board Member 53 22-01-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 257,200,000 179,425,128 ( 69.76 %) 75,700,000 ( 29.43 %) 69.76 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.58 %
21,078,187 11.58 % 5 330 M $
The Vanguard Group, Inc.
11.58 %
21,077,827 11.58 % 5 330 M $
BlackRock Advisors LLC
6.704 %
12,201,638 6.704 % 3 086 M $
Harris Associates LP
5.356 %
9,747,869 5.356 % 2 465 M $
Harris Associates LP
5.356 %
9,747,869 5.356 % 2 465 M $
7,919,037 4.351 % 2 003 M $
AllianceBernstein LP
2.626 %
4,780,172 2.626 % 1 209 M $
Eaton Vance Management
2.224 %
4,047,647 2.224 % 1 024 M $
Geode Capital Management LLC
2.218 %
4,036,507 2.218 % 1 021 M $
Lazard Asset Management LLC
1.777 %
3,233,930 1.777 % 818 M $

Company contact information

IQVIA Holdings, Inc.

2400 Ellis Road

27703, Durham

+919 998 2000

http://www.iqvia.com
address Iqvia Holdings Inc

Group companies

NameCategory and Sector
Data Processing Services
Miscellaneous Commercial Services
Miscellaneous Commercial Services
Quintiles Phase One Clinical Trials India Pvt Ltd.
IMS Software Services Ltd.
Data Processing Services
IMS Health BV
Miscellaneous Commercial Services
Miscellaneous Commercial Services
  1. Stock Market
  2. Equities
  3. IQV Stock
  4. Stock
  5. Company Iqvia Holdings Inc